IN FOCUS FEATURE
WFU Scientists Use Grant, Tiny Beads to Hunt Big Cancer Drugs
FROM OUR WEB SITE
WFU Scientists Use Grant, Tiny Beads to Hunt Big Cancer Drugs
Researchers at Wake Forest University use the fast-changing tools of nanotechnology to search for new cancer-fighting drugs through a process that could be up to 10,000 times faster than current methods. A $75,000 grant from the North Carolina Biotechnology Center is helping this endeaver.
Read more about the research at WFU in this week’s In Focus.
From Our Web Site
Inspire in 2nd Glaucoma Test
Durham-based Inspire Pharmaceuticals has initiated a Phase 1 clinical trial with its second experimental drug for the treatment of glaucoma.
Aldagen Opts Out of IPO
Aldagen has joined other young North Carolina biotech companies in stepping back from a foray into public ownership as Wall Street flails.
ScienceDirect Opportunity Deadline Nov. 1
The North Carolina Biotechnology Center's Library is holding its annual consortium to provide desktop access to Elsevier B.V.'s Corporate Edition of ScienceDirect full-text science journals.
Feds Give Novozymes $12.3M
Novozymes, the Danish biotechnology company with U.S. headquarters in Franklinton, has received a $12.3 million contract from the U.S. Department of Energy, aimed at reducing the cost of cellulosic ethanol production.
Trana Puts $250K Loan to Work
Cary-based Trana Discovery is putting a $250,000 Small Business Research Loan to work commercializing Trana's proprietary technology for quickly identifying new drugs to fight staph infection.
BioDelivery Closer to Market
Raleigh-based BioDelivery Sciences is moving closer to FDA market approval for its flagship cancer-pain mouth patch product, ONSOLIS.
Biogen Shows Leukemia Hope
A lymphoma treatment developed by Biogen Idec has shown strong promise in a late-stage human clinical trial as a leukemia treatment.
Salix Reports Good Results
Morriville-based Salix reported positive results in a clinical trial of its traveler's diarrhea drug rifaximin in treating patients with diarrhea-predominant irritable bowel syndrome.
Register Now for Science-Business Forum
Join your colleagues October 22 in helping shape the future of North Carolina's bioscience workforce at the Science - Business Partnership Forum.
Biolex Closes on $60M Infusion
Pittsboro-based Biolex has again parlayed early Biotechnology Center funding support by adding a $60 million Series D round of venture funding to its previous infusions of more than $113 million and expanding its lock on Locteron.
WFU Catheter Spinout Opens
Applied Catheter Technologies, a Wake Forest University School of Medicine spin-out, has set up shop in the Piedmont Triad Research Park to develop scar-fighting drug-coated catheters and stents.
Ag Race Beyond Cows, Plows
Officials want to encourage students to consider agriculture-related careers in biotechnology.
From the (Raleigh) News & Observer
Mapes Named to NC Community College Leadership Program
The biotechnology chair at Asheville-Buncombe Technical Community College has been accepted into the program, which trains and develops future community college leaders.
From Asheville Citizen-Times
N.C. BioNetwork to Fund National Center for Biotechnology Workforce
The BioNetwork will provide $200,000 to support the center’s director, staff of fewer than five people, and other expenses such as travel.
From Local Tech Wire
Pittsboro Biotech Raises Money
The latest round of funding attracted by Biolex Therapeutics is thought to be the largest round of venture capital ever raised by a Triangle life science company.
From the (Raleigh) News & Observer
Community Watch
- Marjorie Benbow, director of the North Carolina Biotechnology Center's Greater Charlotte Office, was appointed to the board of the Charlotte Area Science Network – a collaboration of science leaders working to foster community, education and industry partnerships to promote science for life in the Charlotte area.
- Morrisville-based Phase Bioscience has named Craig Rosen its executive chairman. Rosen is the former president and chief scientific officer of Human Genome Sciences and co-founder, chief scientific officer and executive chairman of CoGenesys, which Teva Biopharmaceuticals acquired for $400 million earlier this year. More
RTI International has named biologist Rochelle Tyl, Ph.D., as one of the first to be promoted from the position of senior fellow to the designation of distinguished fellow – a career level reserved for individuals who have demonstrated a sustained record of scientific accomplishments that have had a significant impact on RTI and society. RTI now has eight staff members recognized as distinguished fellows. More
November 20
BIO Planning Meeting
(Durham)
December 4-5
SE BIO Investor Forum
(Palm Beach, Fla.)
February 16-17
Biotech 2009
(Raleigh)
May 18-21
BIO International Convention
(Atlanta)
View our complete listing of events across North Carolina.
This newsletter was sent Thursday, October 9, 2008. For the latest headlines from North Carolina’s biotechnology industry, please visit the news section of our Web site.
Online subscription management is now available. Please respond to this e-mail if you cannot change your preferences online.